Filing Flows › Camp4 Therapeutics (CAMP) › Recalls, complaints & regulation
Camp4 Therapeutics (CAMP): clinical trials
Camp4 Therapeutics (CAMP) beyond its filings: 1 active clinical trial.
Camp4 Therapeutics' latest quarter
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Camp4 Therapeutics have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.